TherapeuticsMD Inc (TXMD): In February 2011, the Company relocated...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	68
Posts	1462
Boards Moderated	1
Alias Born	03/26/2010

Hostile Takeover

Re: Hostile Takeover post# 36

Monday, 05/30/2011 12:51:53 AM

Monday, May 30, 2011 12:51:53 AM

In February 2011, the Company relocated its corporate offices to:

10611 N. Hayden Rd., Suite D106, Scottsdale, Arizona 85260.

I'm going to make my world a better place.

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent TXMD News

Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2024 09:00:30 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/26/2024 09:40:29 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/23/2024 10:18:08 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2024 09:16:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 08:10:09 PM
TherapeuticsMD Announces Second Quarter 2024 Financial Results • Business Wire • 08/12/2024 08:05:00 PM
Form AW - Amendment Withdrawal Request • Edgar (US Regulatory) • 06/14/2024 09:00:03 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:18:59 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/10/2024 08:15:43 PM
TherapeuticsMD Announces First Quarter 2024 Financial Results • Business Wire • 05/10/2024 08:05:00 PM
TherapeuticsMD Announces Full Year 2023 Financial Results • Business Wire • 03/29/2024 08:00:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/07/2023 09:51:56 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/06/2023 04:36:35 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 11/17/2023 02:28:51 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/17/2023 02:27:23 PM
TherapeuticsMD Announces Third Quarter 2023 Financial Results • Business Wire • 11/14/2023 09:05:00 PM

More TXMD News

InvestorsHub NewsWire

FEATURED ZenaTech, Inc. (NASDAQ: ZENA) First US Trial of IQ Nano Drone for Inventory Management • Oct 15, 2024 8:21 AM

Kona Gold Beverages, Inc. Announces Strategic Progress and Corporate Evolution • KGKG • Oct 15, 2024 9:00 AM

One World Products Secures First Order for Hemp-Based Reusable Containers, Pioneers Renewable Materials for the Automotive Industry • OWPC • Oct 15, 2024 8:35 AM

CBD Life Sciences, Inc. Announces Strategic MOU with U.S. Armed Forces for Groundbreaking Mushroom Supplement • CBDL • Oct 15, 2024 8:00 AM

HealthLynked Files Non-Provisional Patent for AI-Powered Healthcare Assistant, ARi • HLYK • Oct 15, 2024 8:00 AM

ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover